Endocrine-targeting therapies shift the breast microbiome to reduce estrogen receptor-α breast cancer risk.
Arnone AA, Tsai YT, Cline JM, Wilson AS, Westwood B, Seger ME, Chiba A, Howard-McNatt M, Levine EA, Thomas A, Soto-Pantoja DR, Cook KL.
Arnone AA, et al. Among authors: seger me.
Cell Rep Med. 2024 Dec 26:101880. doi: 10.1016/j.xcrm.2024.101880. Online ahead of print.
Cell Rep Med. 2024.
PMID: 39742868
Free article.